About Naari Pharma Private Limited
Data last updated: 18 December 2025
Naari Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Tenshi Pharmaceuticals Private Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 23 February 1978, the company has been in operation for over 48 years.
Registered with ROC Bangalore under CIN U74899KA1978PTC142872.
Capital: an authorised share capital of ₹86.83 Cr and a paid-up capital of ₹2.7 Cr. Formerly known as Indo Phyto Chemicals Private Limited. It is led by directors including Hermann Osterwald and Prithipal Singh Kochhar.
Last AGM: 12 August 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No.30 Galaxy 1St Main Road Jp Nagar Third Phase, Bangalore, Karnataka, India – 560078.
As per the financials filed for FY 2025, the company reported a revenue of ₹136.35 Cr, a growth of 14% compared to the previous year.
The company has a workforce of approximately 186 employees as per the latest available data. It operates as a subsidiary of Tenshi Pharmaceuticals Private Limited.
The company is associated with 1 brand - Naari. As per MCA filings, the company has open charges of ₹104.5 Cr and satisfied charges of ₹185.45 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website naari.co.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressPlot No.30 Galaxy 1St Main Road Jp Nagar Third Phase, Bangalore, Karnataka, India – 560078
-
IndustryPharma, Drug Formulation & Development, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Naari Pharma Private Limited
Naari Pharma Private Limited has one previous CIN (Corporate Identification Number): U74899DL1978PTC008881. The current CIN is U74899KA1978PTC142872, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74899KA1978PTC142872 | Current |
| U74899DL1978PTC008881 | Previous |
Associated Brands with Naari Pharma Private Limited
Naari Pharma Private Limited operates one associated brand: Naari. These brands represent Naari Pharma Private Limited's diversified market presence and brand portfolio.
Competitors & Alternatives of Naari Pharma Private Limited
Brands and companies operating in the same space as Naari Pharma Private Limited include Sprout Pharmaceuticals, Rejoni, Hope Medicine and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Sprout Pharmaceuticals
|
Drugs for hypoactive sexual desire disorder in women are developed. | Raleigh, United States, United States | 2011 |
Rejoni
|
Therapeutics for women's health conditions are developed using innovative hydrogels. | Bedford, United States, United States | 2020 |
Hope Medicine
|
Monoclonal antibodies are developed for treating multiple diseases. | Shanghai, China, China | 2018 |
Gameto
|
Therapeutics for fertility and menopause treatments are developed. | United States | 2020 |
ObsEva
|
Therapeutics for women's reproductive health and pregnancy are developed. | Geneva, Switzerland, Switzerland | 2012 |
Forendo Pharma
|
Small molecule therapeutics for reproductive health are developed. | Turku, Finland, Finland | 2013 |
Nora Therapeutics
|
Therapeutics for IVF failure and recurrent pregnancy loss are developed. | Palo Alto, United States, United States | 2007 |
PregLem
|
Innovative drugs for women's reproductive medicine are developed and commercialized. | Geneva, Switzerland, Switzerland | 2006 |
Business Activity of Naari Pharma Private Limited
Naari Pharma Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Naari Pharma Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Naari Pharma Private Limited
Naari Pharma Private Limited is audited by DELOITTE HASKINS & SELLS LLP for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DELOITTE HASKINS & SELLS LLP | Locked | Locked | Locked |
Complete auditor history for Naari Pharma Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Naari Pharma Private Limited
Naari Pharma Private Limited is currently managed by 4 directors, with 12 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hermann Osterwald | Nominee Director | 30 Sep 2020 | 5 Years 10 Months | Current |
|
Prithipal Singh Kochhar
Also directs:
Aresko Global Llp, Jagson Pal Pharmaceuticals Limited., I.K. Enterprises Private Limited and 5 more
|
Whole-Time Director | 15 Apr 2015 | 11 Years 4 Months | Current |
|
Pudhucode Radhakrishnan Kannan
Also directs:
Dvise Medtech Private Limited, Serovia Pharma Private Limited, Dvise Pharma Tech Private Limited and 4 more
|
Nominee Director | 24 Jul 2025 | 1 Years 0 Months | Current |
| Deepak Komaregowda | Nominee Director | 06 Dec 2019 | 6 Years 8 Months | Current |
Financials of Naari Pharma Private Limited FY 2025 filings available
Naari Pharma Private Limited reported revenue of ₹136.35 Cr (up 14.00% YoY) for FY 2025.
Ten-year financial statements for Naari Pharma Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Naari Pharma Private Limited
Shareholding and ownership data for Naari Pharma Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Naari Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 May 2022 | Tata Capital Financial Services Limited | ₹2 Cr | Open |
| 27 Dec 2021 | Tata Capital Financial Services Limited | ₹4 Cr | Open |
| 30 Sep 2021 | Hdfc Bank Limited | ₹44.5 Cr | Open |
| 17 Feb 2020 | Others | ₹30 Cr | Open |
| 29 Nov 2019 | Tata Capital Financial Services Limited | ₹24 Cr | Open |
Total charge records: 14 View all charges
Employees and EPFO Compliance at Naari Pharma Private Limited
Naari Pharma Private Limited has a workforce of 186 employees as of Mar 05, 2025.
Employee and EPFO history for Naari Pharma Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Naari Pharma Private Limited
GST registrations and filing compliance for Naari Pharma Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Naari Pharma Private Limited
Credit ratings, litigation, and regulatory alerts for Naari Pharma Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Naari Pharma Private Limited
MSME payment history for Naari Pharma Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Naari Pharma Private Limited
Corporate group structure for Naari Pharma Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Naari Pharma Private Limited
MCA filings and documents for Naari Pharma Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Naari Pharma Private Limited
Frequently Asked Questions about Naari Pharma Private Limited
Naari Pharma Private Limited is an active private limited company in the pharma sector based in Bangalore, Karnataka, India. It was incorporated on 23 February 1978 (48+ years old) and is registered under CIN U74899KA1978PTC142872. The company has 186 employees.
Naari Pharma Private Limited reported revenue of ₹136.35 Cr for FY 2025 (up 14.00% YoY).
The current directors of Naari Pharma Private Limited are:
- Hermann Osterwald - Nominee Director
- Prithipal Singh Kochhar - Whole-Time Director
- Pudhucode Radhakrishnan Kannan - Nominee Director
- Deepak Komaregowda - Nominee Director
The primary industry of Naari Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Naari Pharma Private Limited can be reached at the registered office: Plot No.30 Galaxy 1St Main Road Jp Nagar Third Phase, Bangalore, Karnataka, India – 560078, or through the website naari.co.
The authorised capital is ₹86.83 Cr, and the paid-up capital is ₹2.7 Cr.